onwards
Benign hematological disorders ( Thalassemia, G6PD deficiency)
Hematological neoplasms (CML, Myeloma, Transplant)
Bleeding/thrombosis disorders (Hemophilia, platelet dysfunction, VWD, warfarin resistance)
Transfusion (adverse events, infections)
Genetics of benign and malignant hematological disorders
Benign and coagulation disorder: Dr Bushra Moiz and Ms Amna Nasir
Hematological neoplasms: Dr Natasha Ali and Dr Mohammad Usman Shaikh
Transfusion: Dr Farheen Karim
Stem cell transplant: Dr Salman Naseem Adil
Evaluation of bone health in Pakistani patients with B Thalasemia Major 2012-2014.Funded by URC
Estimation of frequency of Factor V Leiden G1691A and prothrombin gene G20210A mutation in patients presenting with recurrent pregnancy loss. (2012). Funded by Department Seed Money Grant
XBP-1 mediated expression of MUC1 maintains the myeloma stem cell pool and facilitates resistance to treatment in myeloma.
The Frequency of VKORC1 and CYP2C9 Polymorphisms Associated With Warfarin Therapy in Patients with Thromboembolism (2014-2016). Submitted & approved Pakistan Science Foundation
Determination of Bone health in hemophilia patients with and without HCV
Determination of platelet resistance in CABG patients receiving aspirin
Gene sequencing of Hemophilia A gene
Dr El-Nasir Lalani and Dr Shireen Rajput ( Myeloma Project)
Dr Aysha Habib and Dr Romaina Iqbal (Thalassemia project)
Dr Irfan Hashmi (Stem cell project)
Dr Bushra MoizHead, Section of Hematology